FOSCHINI, FULVIO,STAGNI, MARCELLO,LUCIANI, GIULIO,ROY, PIERRE
申请号：
CA2851331
公开号：
CA2851331A1
申请日:
2012.10.24
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus.
